15084390Otterson GA, Herndon JE, Watson D, Green MR, Kindler HL, Cancer and Leukemia Group BLung cancer (Amsterdam, Netherlands)Antimetabolites, Antineoplastic; Deoxycytidine; Mesothelioma; Pleural NeoplasmsAdministration, Oral; Adult; Aged; Aged, 80 and over; Capecitabine; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Treatment OutcomeCapecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807). Lung Cancer. 2004 May; 44(2):251-9.Lung Cancer2004-05-01T00:00:002004Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461294Aged, 80 and overD000368Living Beings1341183530.294764AgedD000284Procedures2556830.864689Administration, OralD000328Living Beings1578255770.254432AdultD000964Chemicals & Drugs822360.870497Antimetabolites, AntineoplasticD005472Chemicals & Drugs1085560.85543FluorouracilAuthorship 246555D008654Disorders573090.774622MesotheliomaD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD005260Physiology1992444050.191167FemaleD010997Disorders361880.842535Pleural NeoplasmsD006801Living Beings2262862810.130052HumansD008297Physiology1931408600.201617Male0.06290460.06290461authors10.2516has subject areaMedicine-Hematology and OncologyD016896Concepts & Ideas101179490.402389Treatment OutcomeD00006928742950.952268CapecitabineD003841Chemicals & Drugs762370.888267DeoxycytidineD018572Concepts & Ideas25812030.792696Disease-Free SurvivalUniversity of ChicagoHedyKindler32lgBaUZHP75hHlsaUXv9Gq0+s+oHedy Kindler41.78927490000000-87.601250000000002499Kindler, HedyProfessortrue1ProfessorProfessor